Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway
NCT04663386 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 29
Last updated 2021-09-23
Summary
This is a retrospective, multicentre, non-interventional, observational study in patients with asthma and/or COPD who are treated with budesonide-formoterol.
Conditions
Interventions
- DRUG
-
Budesonide-Formoterol
Dry powder inhaler
Sponsors & Collaborators
-
Orion Corporation, Orion Pharma
lead INDUSTRY
Principal Investigators
-
Jorn Ossum · Flattum Legesenter
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-10
- Primary Completion
- 2021-09-14
- Completion
- 2021-09-14
Countries
- Norway
Study Locations
More Related Trials
-
Budesonide / Formoterol in Treatment of Exacerbations of COPD
NCT00239278 ·Status: COMPLETED ·Phase: PHASE2
-
Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients
NCT01803087 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Pharmacokinetic Study (BF-BLOCK)
NCT01423305 ·Status: COMPLETED ·Phase: PHASE1
-
To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product
NCT02308098 ·Status: COMPLETED ·Phase: PHASE3
-
The Asthma Bronchial Challenge Study
NCT03575663 ·Status: COMPLETED
-
Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI
NCT01349257 ·Status: COMPLETED ·Phase: PHASE2
-
Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD)
NCT03197818 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Between Symbicort® and Prednisolone in COPD
NCT00259779 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD
NCT00476099 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.
NCT04078126 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/Formoterol
NCT01023516 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
NCT01436110 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma
NCT00476073 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With a Next-Generation Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
NCT05573464 ·Status: COMPLETED ·Phase: PHASE3
-
A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)
NCT00239421 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus
NCT01856621 ·Status: COMPLETED ·Phase: PHASE1
-
Validation of Questionnaire and Assessment of Patient Satisfaction for Budesonide/Formoterol Fix Combination Dry Powder Inhalers (DPI) in Chronic Obstructive Pulmonary Disease (COPD)
NCT01646424 ·Status: COMPLETED
-
Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)
NCT00742248 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma
NCT04665895 ·Status: COMPLETED ·Phase: PHASE3
-
Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics
NCT00364442 ·Status: COMPLETED ·Phase: PHASE1
-
Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient (FORSYYN)
NCT03888131 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of "Nexthaler" Dry Powder Inhaler in COPD Patients
NCT02000609 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older
NCT02437604 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects
NCT02991859 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus
NCT03060044 ·Status: COMPLETED ·Phase: PHASE1